Home » Author Archive

Image for Invesco S&P SmallCap Momentum ETF (NYSEARCA:PXSG) Share Price Crosses Below Two Hundred Day Moving Average of $52.65

Invesco S&P SmallCap Momentum ETF (NYSEARCA:PXSG) Share Price Crosses Below Two Hundred Day Moving Average of $52.65

Invesco S&P SmallCap Momentum ETF (NYSEARCA:PXSG – Get Rating)’s stock price crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $52.65 and... More of this article »
Image for Fujitsu (OTCMKTS:FJTSY) Share Price Crosses Below 200 Day Moving Average of $31.41

Fujitsu (OTCMKTS:FJTSY) Share Price Crosses Below 200 Day Moving Average of $31.41

Fujitsu Limited (OTCMKTS:FJTSY – Get Rating)’s stock price crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $31.41 and traded as low as $30.21. Fujitsu shares... More of this article »
Image for Big Cypress Acquisition (OTCMKTS:BCYP) Share Price Passes Below 200-Day Moving Average of $8.44

Big Cypress Acquisition (OTCMKTS:BCYP) Share Price Passes Below 200-Day Moving Average of $8.44

Big Cypress Acquisition Corp. (OTCMKTS:BCYP – Get Rating) shares crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $8.44 and traded as low as $8.21.... More of this article »
Image for eServGlobal (LON:ESG) Shares Cross Below 200-Day Moving Average of $5.45

eServGlobal (LON:ESG) Shares Cross Below 200-Day Moving Average of $5.45

eServGlobal Limited (LON:ESG – Get Rating) shares passed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 5.45 ($0.07) and traded as low as GBX 4.88 ($0.06).... More of this article »
Image for Gouverneur Bancorp (OTCMKTS:GOVB) Shares Cross Below 200-Day Moving Average of $9.36

Gouverneur Bancorp (OTCMKTS:GOVB) Shares Cross Below 200-Day Moving Average of $9.36

Gouverneur Bancorp, Inc. (OTCMKTS:GOVB – Get Rating)’s stock price passed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $9.36 and traded as low as... More of this article »
Image for Byotrol (LON:BYOT) Shares Pass Below 200-Day Moving Average of $3.73

Byotrol (LON:BYOT) Shares Pass Below 200-Day Moving Average of $3.73

Byotrol plc (LON:BYOT – Get Rating)’s stock price crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 3.73 ($0.05) and traded as low as GBX... More of this article »
Image for Moog (NYSE:MOG.B) Share Price Passes Below Two Hundred Day Moving Average of $80.77

Moog (NYSE:MOG.B) Share Price Passes Below Two Hundred Day Moving Average of $80.77

Shares of Moog Inc (NYSE:MOG.B – Get Rating) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $80.77 and traded as low as $75.91. Moog shares last traded at $75.91,... More of this article »
Image for First Northern Community Bancorp (OTCMKTS:FNRN) Share Price Crosses Below 200-Day Moving Average of $10.28

First Northern Community Bancorp (OTCMKTS:FNRN) Share Price Crosses Below 200-Day Moving Average of $10.28

First Northern Community Bancorp (OTCMKTS:FNRN – Get Rating) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $10.28 and traded as low as $9.00. First Northern Community... More of this article »
Image for Gyrodyne (NASDAQ:GYRO) Share Price Crosses Above 200 Day Moving Average of $12.34

Gyrodyne (NASDAQ:GYRO) Share Price Crosses Above 200 Day Moving Average of $12.34

Shares of Gyrodyne, LLC (NASDAQ:GYRO – Get Rating) passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $12.34 and traded as high as $12.64. Gyrodyne shares... More of this article »
Image for Financial Analysis: Northeast Community Bancorp (NECB) and Its Competitors

Financial Analysis: Northeast Community Bancorp (NECB) and Its Competitors

Northeast Community Bancorp (OTCMKTS:NECB – Get Rating) is one of 36 public companies in the “Savings institutions, except federal” industry, but how does it contrast to its competitors? We will compare Northeast... More of this article »
Image for Sidus Space (NASDAQ:SIDU) versus TELUS (NYSE:TU) Critical Review

Sidus Space (NASDAQ:SIDU) versus TELUS (NYSE:TU) Critical Review

Sidus Space (NASDAQ:SIDU – Get Rating) and TELUS (NYSE:TU – Get Rating) are both aerospace companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends,... More of this article »
Image for Zacks Investment Research Upgrades Adaptimmune Therapeutics (NASDAQ:ADAP) to Hold

Zacks Investment Research Upgrades Adaptimmune Therapeutics (NASDAQ:ADAP) to Hold

Adaptimmune Therapeutics (NASDAQ:ADAP – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Monday, Zacks.com reports. According to Zacks,... More of this article »
Image for Reviewing Accel Entertainment (ACEL) & Its Rivals

Reviewing Accel Entertainment (ACEL) & Its Rivals

Accel Entertainment (NYSE:ACEL – Get Rating) is one of 34 public companies in the “Amusement & recreation services” industry, but how does it weigh in compared to its competitors? We will compare Accel Entertainment... More of this article »
Image for BTIG Research Cuts LifeMD (NASDAQ:LFMD) Price Target to $8.00

BTIG Research Cuts LifeMD (NASDAQ:LFMD) Price Target to $8.00

LifeMD (NASDAQ:LFMD – Get Rating) had its price target cut by analysts at BTIG Research to $8.00 in a research note issued to investors on Monday, Stock Target Advisor reports. The brokerage presently has a “na”... More of this article »
Image for Blue Star Foods (OTCMKTS:BSFC) Rating Increased to Hold at Zacks Investment Research

Blue Star Foods (OTCMKTS:BSFC) Rating Increased to Hold at Zacks Investment Research

Blue Star Foods (OTCMKTS:BSFC – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Monday, Zacks.com reports.... More of this article »
Image for ageas SA/NV (OTCMKTS:AGESY) Lifted to “Hold” at Zacks Investment Research

ageas SA/NV (OTCMKTS:AGESY) Lifted to “Hold” at Zacks Investment Research

ageas SA/NV (OTCMKTS:AGESY – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Monday, Zacks.com reports. According to Zacks, “Ageas,... More of this article »
Image for JE Cleantech (NASDAQ:JCSE) Stock Price Up 0.5%

JE Cleantech (NASDAQ:JCSE) Stock Price Up 0.5%

JE Cleantech Holdings Limited (NASDAQ:JCSE – Get Rating) rose 0.5% during mid-day trading on Tuesday . The stock traded as high as $11.52 and last traded at $11.27. Approximately 20,864 shares were traded during mid-day trading,... More of this article »
Image for Zoom Video Communications (NASDAQ:ZM) Rating Increased to Hold at Zacks Investment Research

Zoom Video Communications (NASDAQ:ZM) Rating Increased to Hold at Zacks Investment Research

Zoom Video Communications (NASDAQ:ZM – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Monday, Zacks.com reports. The firm currently... More of this article »
Image for Brokers Issue Forecasts for Golub Capital BDC, Inc.’s Q3 2022 Earnings (NASDAQ:GBDC)

Brokers Issue Forecasts for Golub Capital BDC, Inc.’s Q3 2022 Earnings (NASDAQ:GBDC)

Golub Capital BDC, Inc. (NASDAQ:GBDC – Get Rating) – Analysts at Oppenheimer dropped their Q3 2022 earnings per share estimates for Golub Capital BDC in a report issued on Wednesday, May 11th. Oppenheimer analyst M.... More of this article »
Image for Brokers Set Expectations for PDS Biotechnology Co.’s Q3 2022 Earnings (NASDAQ:PDSB)

Brokers Set Expectations for PDS Biotechnology Co.’s Q3 2022 Earnings (NASDAQ:PDSB)

PDS Biotechnology Co. (NASDAQ:PDSB – Get Rating) – Stock analysts at Oppenheimer lifted their Q3 2022 EPS estimates for PDS Biotechnology in a research note issued to investors on Thursday, May 12th. Oppenheimer analyst... More of this article »
Image for Jacobs Engineering Group Inc. (NYSE:J) Expected to Earn Q3 2022 Earnings of $1.82 Per Share

Jacobs Engineering Group Inc. (NYSE:J) Expected to Earn Q3 2022 Earnings of $1.82 Per Share

Jacobs Engineering Group Inc. (NYSE:J – Get Rating) – Equities research analysts at KeyCorp reduced their Q3 2022 earnings per share (EPS) estimates for shares of Jacobs Engineering Group in a report issued on Wednesday,... More of this article »
Image for Royal Bank of Canada Increases Centrica (LON:CNA) Price Target to GBX 125

Royal Bank of Canada Increases Centrica (LON:CNA) Price Target to GBX 125

Centrica (LON:CNA – Get Rating) had its price target lifted by stock analysts at Royal Bank of Canada from GBX 90 ($1.11) to GBX 125 ($1.54) in a note issued to investors on Monday, MarketBeat reports. The firm currently has... More of this article »
Image for Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (FRA:MUV2) PT Set at €286.00 by Barclays

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (FRA:MUV2) PT Set at €286.00 by Barclays

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (FRA:MUV2 – Get Rating) received a €286.00 ($297.92) price objective from investment analysts at Barclays in a research report issued on Monday,... More of this article »
Image for Antofagasta (LON:ANTO) Stock Rating Reaffirmed by Barclays

Antofagasta (LON:ANTO) Stock Rating Reaffirmed by Barclays

Antofagasta (LON:ANTO – Get Rating)‘s stock had its “overweight” rating reissued by equities researchers at Barclays in a report issued on Monday, Marketbeat Ratings reports. They presently have a GBX 1,645... More of this article »
Image for The National Security Group (NASDAQ:NSEC) Share Price Passes Above Two Hundred Day Moving Average of $13.32

The National Security Group (NASDAQ:NSEC) Share Price Passes Above Two Hundred Day Moving Average of $13.32

The National Security Group, Inc. (NASDAQ:NSEC – Get Rating) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $13.32 and traded as high as $16.34. The National Security... More of this article »
Image for GLI Finance (LON:GLIF) Shares Cross Above 200-Day Moving Average of $2.63

GLI Finance (LON:GLIF) Shares Cross Above 200-Day Moving Average of $2.63

GLI Finance Limited (LON:GLIF – Get Rating) shares passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 2.63 ($0.03) and traded as high as GBX 3 ($0.04). GLI Finance... More of this article »
Image for Wishbone Gold (LON:WSBN) Stock Passes Above 200 Day Moving Average of $8.55

Wishbone Gold (LON:WSBN) Stock Passes Above 200 Day Moving Average of $8.55

Wishbone Gold Plc (LON:WSBN – Get Rating)’s share price passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 8.55 ($0.11) and traded as high as... More of this article »
Image for Cullinan Oncology (NASDAQ:CGEM) Upgraded by Zacks Investment Research to Hold

Cullinan Oncology (NASDAQ:CGEM) Upgraded by Zacks Investment Research to Hold

Cullinan Oncology (NASDAQ:CGEM – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Monday, Zacks.com reports. The firm presently... More of this article »
Image for Capricor Therapeutics (NASDAQ:CAPR) Rating Lowered to Sell at Zacks Investment Research

Capricor Therapeutics (NASDAQ:CAPR) Rating Lowered to Sell at Zacks Investment Research

Capricor Therapeutics (NASDAQ:CAPR – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Monday, Zacks.com reports. According... More of this article »
Image for Bureau Veritas (OTCMKTS:BVRDF) Downgraded by Zacks Investment Research to Sell

Bureau Veritas (OTCMKTS:BVRDF) Downgraded by Zacks Investment Research to Sell

Bureau Veritas (OTCMKTS:BVRDF – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Monday, Zacks.com reports. According to Zacks, “Bureau... More of this article »
Image for Peoples Bancorp (NASDAQ:PEBO) Raised to “Buy” at StockNews.com

Peoples Bancorp (NASDAQ:PEBO) Raised to “Buy” at StockNews.com

Peoples Bancorp (NASDAQ:PEBO – Get Rating) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Monday. PEBO has been the subject of a number of... More of this article »
Image for Mimecast (NASDAQ:MIME) Rating Increased to Buy at StockNews.com

Mimecast (NASDAQ:MIME) Rating Increased to Buy at StockNews.com

Mimecast (NASDAQ:MIME – Get Rating) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Monday. Several other analysts have also... More of this article »
Image for Chesswood Group (TSE:CHW) PT Raised to C$25.00

Chesswood Group (TSE:CHW) PT Raised to C$25.00

Chesswood Group (TSE:CHW – Get Rating) had its target price raised by equities researchers at Cormark from C$24.25 to C$25.00 in a report issued on Monday, MarketBeat Ratings reports. Cormark’s price target would suggest... More of this article »
Image for Medical Facilities (TSE:DR) Price Target Lowered to C$11.00 at Royal Bank of Canada

Medical Facilities (TSE:DR) Price Target Lowered to C$11.00 at Royal Bank of Canada

Medical Facilities (TSE:DR – Get Rating) had its target price cut by stock analysts at Royal Bank of Canada from C$12.00 to C$11.00 in a report issued on Monday, BayStreet.CA reports. The brokerage currently has a “sector... More of this article »
Image for TD Securities Lowers Capstone Copper (TSE:CS) Price Target to C$7.50

TD Securities Lowers Capstone Copper (TSE:CS) Price Target to C$7.50

Capstone Copper (TSE:CS – Get Rating) had its target price dropped by analysts at TD Securities from C$9.00 to C$7.50 in a report released on Monday, BayStreet.CA reports. The firm presently has a “buy” rating on... More of this article »
Image for Capstone Copper (TSE:CS) Price Target Cut to C$7.00 by Analysts at BMO Capital Markets

Capstone Copper (TSE:CS) Price Target Cut to C$7.00 by Analysts at BMO Capital Markets

Capstone Copper (TSE:CS – Get Rating) had its target price lowered by BMO Capital Markets from C$8.00 to C$7.00 in a report issued on Monday, BayStreet.CA reports. BMO Capital Markets’ target price would indicate a potential... More of this article »
Image for Definity Financial (TSE:DFY) Given New C$36.00 Price Target at Cormark

Definity Financial (TSE:DFY) Given New C$36.00 Price Target at Cormark

Definity Financial (TSE:DFY – Get Rating) had its price objective lowered by investment analysts at Cormark from C$38.00 to C$36.00 in a research note issued to investors on Monday, Marketbeat.com reports. Cormark’s price... More of this article »
Image for ABC Technologies (TSE:ABCT) PT Raised to C$8.00

ABC Technologies (TSE:ABCT) PT Raised to C$8.00

ABC Technologies (TSE:ABCT – Get Rating) had its price objective upped by JPMorgan Chase & Co. from C$7.00 to C$8.00 in a note issued to investors on Monday, BayStreet.CA reports. JPMorgan Chase & Co.‘s price... More of this article »
Image for Shawcor (TSE:SCL) Upgraded by TD Securities to Buy

Shawcor (TSE:SCL) Upgraded by TD Securities to Buy

Shawcor (TSE:SCL – Get Rating) was upgraded by analysts at TD Securities from a “hold” rating to a “buy” rating in a report released on Monday, BayStreet.CA reports. The firm presently has a C$7.50 price... More of this article »
Image for BioLineRx Ltd. (NASDAQ:BLRX) Expected to Post Q2 2022 Earnings of ($0.15) Per Share

BioLineRx Ltd. (NASDAQ:BLRX) Expected to Post Q2 2022 Earnings of ($0.15) Per Share

BioLineRx Ltd. (NASDAQ:BLRX – Get Rating) – Stock analysts at Zacks Investment Research issued their Q2 2022 earnings per share (EPS) estimates for BioLineRx in a research note issued to investors on Thursday, May 12th.... More of this article »
Image for Equities Analysts Set Expectations for Atreca, Inc.’s Q2 2022 Earnings (NASDAQ:BCEL)

Equities Analysts Set Expectations for Atreca, Inc.’s Q2 2022 Earnings (NASDAQ:BCEL)

Atreca, Inc. (NASDAQ:BCEL – Get Rating) – Equities research analysts at Jefferies Financial Group raised their Q2 2022 earnings per share (EPS) estimates for Atreca in a research note issued to investors on Wednesday,... More of this article »
Image for Neo Performance Materials (TSE:NEO) PT Lowered to C$25.00

Neo Performance Materials (TSE:NEO) PT Lowered to C$25.00

Neo Performance Materials (TSE:NEO – Get Rating) had its target price reduced by research analysts at Scotiabank from C$27.00 to C$25.00 in a report issued on Monday, BayStreet.CA reports. Scotiabank’s price target indicates... More of this article »
Image for B&G Foods, Inc. to Post Q2 2022 Earnings of $0.21 Per Share, Seaport Res Ptn Forecasts (NYSE:BGS)

B&G Foods, Inc. to Post Q2 2022 Earnings of $0.21 Per Share, Seaport Res Ptn Forecasts (NYSE:BGS)

B&G Foods, Inc. (NYSE:BGS – Get Rating) – Equities research analysts at Seaport Res Ptn dropped their Q2 2022 earnings estimates for B&G Foods in a research report issued on Wednesday, May 11th. Seaport Res... More of this article »
Image for Q2 2022 EPS Estimates for Compass Therapeutics, Inc. (NASDAQ:CMPX) Boosted by Analyst

Q2 2022 EPS Estimates for Compass Therapeutics, Inc. (NASDAQ:CMPX) Boosted by Analyst

Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Rating) – Investment analysts at Wedbush boosted their Q2 2022 earnings estimates for Compass Therapeutics in a research note issued on Thursday, May 12th. Wedbush analyst... More of this article »
Image for Q2 2022 EPS Estimates for ForgeRock, Inc. Decreased by Analyst (NYSE:FORG)

Q2 2022 EPS Estimates for ForgeRock, Inc. Decreased by Analyst (NYSE:FORG)

ForgeRock, Inc. (NYSE:FORG – Get Rating) – Equities researchers at KeyCorp decreased their Q2 2022 earnings estimates for shares of ForgeRock in a research report issued to clients and investors on Wednesday, May 11th.... More of this article »
Image for Clearside Biomedical, Inc. to Post Q2 2022 Earnings of ($0.13) Per Share, Wedbush Forecasts (NASDAQ:CLSD)

Clearside Biomedical, Inc. to Post Q2 2022 Earnings of ($0.13) Per Share, Wedbush Forecasts (NASDAQ:CLSD)

Clearside Biomedical, Inc. (NASDAQ:CLSD – Get Rating) – Equities research analysts at Wedbush lowered their Q2 2022 EPS estimates for Clearside Biomedical in a research note issued to investors on Thursday, May 12th.... More of this article »
Image for Achilles Therapeutics (NASDAQ:ACHL) Downgraded to “Hold” at Zacks Investment Research

Achilles Therapeutics (NASDAQ:ACHL) Downgraded to “Hold” at Zacks Investment Research

Achilles Therapeutics (NASDAQ:ACHL – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Monday, Zacks.com reports. According to... More of this article »
Image for Vodafone Group Public (LON:VOD) Rating Reiterated by JPMorgan Chase & Co.

Vodafone Group Public (LON:VOD) Rating Reiterated by JPMorgan Chase & Co.

Vodafone Group Public (LON:VOD – Get Rating)‘s stock had its “overweight” rating restated by research analysts at JPMorgan Chase & Co. in a report issued on Monday, MarketBeat reports. They currently have... More of this article »
Image for NEXT (LON:NXT) Stock Rating Reaffirmed by Royal Bank of Canada

NEXT (LON:NXT) Stock Rating Reaffirmed by Royal Bank of Canada

NEXT (LON:NXT – Get Rating)‘s stock had its “outperform” rating reiterated by investment analysts at Royal Bank of Canada in a research note issued on Monday, MarketBeat reports. They presently have a GBX 7,200... More of this article »
Image for Critical Analysis: Eqonex (NASDAQ:EQOS) & Broadridge Financial Solutions (NYSE:BR)

Critical Analysis: Eqonex (NASDAQ:EQOS) & Broadridge Financial Solutions (NYSE:BR)

Eqonex (NASDAQ:EQOS – Get Rating) and Broadridge Financial Solutions (NYSE:BR – Get Rating) are both finance companies, but which is the superior business? We will compare the two companies based on the strength of their... More of this article »